ROBYN MOORE: Open Payments
NPI 1669907028 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,649 in 102 payments from 22 companies in 2025. Trend: 2023 $812 · 2024 $608 · 2025 $3,649
Food & beverage: $3,572Education: $77
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $691 |
| ABBVIE INC. | 32 | $662 |
| AstraZeneca Pharmaceuticals LP | 6 | $412 |
| Janssen Biotech, Inc. | 8 | $280 |
| UCB, Inc. | 10 | $259 |
| Lundbeck LLC | 2 | $167 |
| Mallinckrodt Hospital Products Inc. | 2 | $153 |
| Abbott Laboratories | 1 | $150 |
| GENZYME CORPORATION | 2 | $133 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
Products named: RINVOQ, TAVNEOS, SKYRIZI, SAPHNELO, TREMFYA, Bimzelx, KRYSTEXXA, REXULTI.
Industry payments across KS — which companies pay providers there.
